Inverter apparatus with improved gate drive for power MOSFET
    11.
    发明授权
    Inverter apparatus with improved gate drive for power MOSFET 有权
    用于功率MOSFET的改进的栅极驱动的逆变器装置

    公开(公告)号:US07551004B2

    公开(公告)日:2009-06-23

    申请号:US11337595

    申请日:2006-01-24

    IPC分类号: H03K3/00

    CPC分类号: H03K17/08122 H03K17/163

    摘要: An inverter apparatus is composed of a power MOSFET having a source/drain connected to an output terminal, and a gate drive circuit driving a gate of the power MOSFET. The gate drive circuit includes a discharging path connected with the gate of the power MOSFET. The discharging path includes a set of serially-connected diodes which are forward-connected in a direction of a discharge current from the gate of the power MOSFET.

    摘要翻译: 逆变器装置由具有与输出端子连接的源极/漏极的功率MOSFET和驱动功率MOSFET的栅极的栅极驱动电路构成。 栅极驱动电路包括与功率MOSFET的栅极连接的放电路径。 放电路径包括一组串联连接的二极管,其在来自功率MOSFET的栅极的放电电流的方向上正向连接。

    DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL

    公开(公告)号:US20080090304A1

    公开(公告)日:2008-04-17

    申请号:US11770245

    申请日:2007-06-28

    IPC分类号: G01N33/53 G01N33/68

    摘要: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.

    Detection of NGAL in chronic renal disease
    13.
    发明申请
    Detection of NGAL in chronic renal disease 审中-公开
    慢性肾脏疾病中NGAL的检测

    公开(公告)号:US20070037232A1

    公开(公告)日:2007-02-15

    申请号:US11374285

    申请日:2005-10-13

    IPC分类号: G01N33/53

    摘要: Methods of assessing the ongoing kidney status in a subject afflicted with chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in fluid samples over time is disclosed. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the urine and serum as a result of chronic renal tubule cell injury. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.

    摘要翻译: 公开了通过随时间检测流体样品中嗜中性粒细胞明胶酶相关脂质运载蛋白(NGAL)的量来评估患有慢性肾功能衰竭(CRF)的受试者正在进行的肾脏状态的方法。 NGAL是一种小分泌的多肽,其是蛋白酶抗性的,因此由于慢性肾小管细胞损伤在尿液和血清中容易检测到。 长时间的CRF患者NGAL水平的增加增加是肾脏疾病恶化的诊断。 NGAL的这种增加先于CRF恶化的其他指标,如增加血清肌酐,增加尿蛋白分泌,降低肾小球滤过率(GFR)。 通过患者治疗前和治疗后的NGAL水平证实,正确检测恶化(或改善,如果治疗已经建立)肾脏状态,可以帮助临床从业者设计和/或维持适当的治疗方案缓慢 或停止CRF的进展。

    Charger and integrated circuit
    14.
    发明申请
    Charger and integrated circuit 有权
    充电器和集成电路

    公开(公告)号:US20060076928A1

    公开(公告)日:2006-04-13

    申请号:US11221894

    申请日:2005-09-09

    IPC分类号: H02J7/00

    CPC分类号: H02J7/0052 Y10T307/516

    摘要: A charger of the present invention includes a charging transistor and a charging integrated circuit. The charging transistor is series-connected with a secondary battery to supply a charging current to the secondary battery. The charging integrated circuit is incorporated into a package having a higher heat releasability than that of the charging transistor. The charging integrated circuit controls the charging transistor and besides, supplies a charging current to the secondary battery. For this purpose, the charging integrated circuit includes a current source supplying this charging current. The charging current from the current source is supplied to the secondary battery together with the charging current from the charging transistor to charge the secondary battery.

    摘要翻译: 本发明的充电器包括充电晶体管和充电集成电路。 充电晶体管与二次电池串联连接以向二次电池提供充电电流。 充电集成电路被并入具有比充电晶体管更高的散热性的封装。 充电集成电路控制充电晶体管,此外,向二次电池供给充电电流。 为此,充电集成电路包括提供该充电电流的电流源。 来自电流源的充电电流与来自充电晶体管的充电电流一起被提供给二次电池以对二次电池充电。

    Identifying causes of semiconductor production yield loss
    16.
    发明授权
    Identifying causes of semiconductor production yield loss 失效
    确定半导体生产成本损失的原因

    公开(公告)号:US5971586A

    公开(公告)日:1999-10-26

    申请号:US611277

    申请日:1996-03-18

    申请人: Kiyoshi Mori

    发明人: Kiyoshi Mori

    CPC分类号: H01L22/20

    摘要: A method for identifying those process steps which produce "high risk" particulate contamination that is most likely to produce defects. The die positions of particulate deposits on a wafer are measured prior to and subsequent to a specific process step, to determine the die positions of particulate deposits introduced during that specific process step. Then, subsequent electrical tests of the wafer are used to determine which locations on the wafer contain faulty circuitry. The locations of particulate deposits introduced during the specific process step are then correlated to the locations of faulty circuitry. The result is a measure of the extent to which particulate deposits introduced during the specific process step contribute to reductions in yield of the manufacturing process.

    摘要翻译: 一种识别那些最有可能产生缺陷的“高风险”颗粒污染物的工艺步骤的方法。 在特定工艺步骤之前和之后测量在晶片上的颗粒沉积物的模头位置,以确定在该特定工艺步骤期间引入的颗粒沉积物的模具位置。 然后,使用晶片的随后的电测试来确定晶片上的哪些位置包含故障电路。 然后在特定工艺步骤期间引入的颗粒沉积物的位置与故障电路的位置相关。 结果是在特定工艺步骤期间引入颗粒沉积物的程度有助于降低制造过程的产量的量度。

    Vertical floating-gate transistor
    17.
    发明授权
    Vertical floating-gate transistor 失效
    垂直浮栅晶体管

    公开(公告)号:US5016068A

    公开(公告)日:1991-05-14

    申请号:US449135

    申请日:1989-12-08

    申请人: Kiyoshi Mori

    发明人: Kiyoshi Mori

    IPC分类号: H01L27/115

    CPC分类号: H01L27/115

    摘要: An electrically erasable, progammable, read-only-memory, floating-gate, metal-oxide-semiconductor transistor constructed in a trench extending through layers of P-type and N-type material formed on a semiconductor substrate. The floating-gate transistor is comprised of two source-drain regions, a channel region, a floating gate, a programming gate, and gate-oxide layers and is characterized by a floating-gate to channel capacitance that is small relative to the programming-gate to floating-gate capacitance, thereby allowing charging of the floating gate using programming and erasing voltages of less magnitude than might otherwise be necessary.

    摘要翻译: 构造在延伸穿过形成在半导体衬底上的P型和N型材料层的沟槽中的电可擦除,可执行的只读存储器,浮栅,金属氧化物半导体晶体管。 浮栅晶体管由两个源极 - 漏极区,沟道区,浮置栅,编程栅和栅氧化物层组成,其特征在于浮栅对沟道电容相对于编程 - 栅极到浮置栅极电容,从而允许使用比另外可能需要的程度更小的量的编程和擦除电压对浮置栅极进行充电。

    Vertical MOS transistor
    18.
    发明授权
    Vertical MOS transistor 失效
    垂直MOS晶体管

    公开(公告)号:US5016067A

    公开(公告)日:1991-05-14

    申请号:US449124

    申请日:1989-12-08

    申请人: Kiyoshi Mori

    发明人: Kiyoshi Mori

    摘要: A transistor structure is disclosed which has a vertical channel which has its length controllable by currently-used diffusion processes, and which occupies a minimum of silicon surface area. The transistor is constructed by using a triple-level implant and diffusion process. The drain region is diffused into the silicon area by way of ion implantation and subsequent diffusion. The channel region, of opposite conductivity-type from the drain region, is implanted and diffused into the drain region. The source region is similarly implanted, and diffused into the channel region. A trench is etched into the silicon, extending through the source, channel and drain regions; gate oxide is grown in the trench and a polysilicon gate is deposited in the trench, conformal with the gate oxide. Transistor action takes place in the channel region along the walls of the trench, dependent upon the voltage applied to the gate electrode. Series drain resistance, and gate-to-drain capacitance, is minimized by a deeper implant of the drain region away from the trench and under the electrical interconnection to the drain diffusion.

    摘要翻译: 公开了一种晶体管结构,其具有垂直通道,其垂直通道的长度可通过当前使用的扩散过程控制,并且占据硅表面积的最小值。 晶体管通过使用三电平植入和扩散工艺构成。 漏极区域通过离子注入和随后的扩散扩散到硅区域。 与漏极区相反的导电类型的沟道区被注入并扩散到漏极区。 源区类似地植入,并扩散到沟道区。 沟槽被蚀刻到硅中,延伸穿过源极,沟道和漏极区; 栅极氧化物在沟槽中生长,并且多晶硅栅极沉积在沟槽中,与栅极氧化物保形。 晶体管的作用发生在沿着沟槽壁的沟道区域中,取决于施加到栅电极的电压。 串联漏极电阻和栅极到漏极电容通过漏极区域远离沟槽和在与漏极扩散的电互连下更深地注入而最小化。

    DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
    20.
    发明申请
    DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL 审中-公开
    使用NGAL诊断和监测慢性肾病

    公开(公告)号:US20100234765A1

    公开(公告)日:2010-09-16

    申请号:US12785237

    申请日:2010-05-21

    IPC分类号: A61B5/00

    摘要: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.

    摘要翻译: 通过检测尿液,血清或血浆中的嗜中性粒细胞明胶酶相关脂质运载蛋白(NGAL)的量来评估患有慢性肾损伤或疾病的哺乳动物的正在进行的肾脏状态的方法,包括慢性肾功能衰竭(CRF) 样品在离散的时间段,以及随着时间的推移。 长时间的CRF患者NGAL水平的增加增加是肾脏疾病恶化的诊断。 NGAL的这种增加先于慢性肾病或CRF恶化的其他指标,如血清肌酐升高,尿蛋白分泌增加,肾小球滤过率(GFR)降低。 通过患者治疗前和治疗后的NGAL水平证实,正确检测恶化(或改善,如果治疗已经建立)肾脏状态,可以帮助临床从业者设计和/或维持适当的治疗方案缓慢 或停止CRF的进展。